Odyssey Therapeutics ODTX
NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

Odyssey Therapeutics (ODTX) Intangibles (2022 - 2026)

Updated

Odyssey Therapeutics' Intangibles came in at $86,000 for Q2 2026, down 46.3% from the prior quarter.

Analysis

Odyssey Therapeutics (ODTX) Intangibles (2022 - 2026) Analysis & Trends

At the end of FY2025, Odyssey Therapeutics' Intangibles was $262,000, down 54.0% from FY2024.

  • Intangibles has declined in each of the last three years, with a three-year compound annual growth rate of -39.4% (FY2022 to FY2025).
  • Going back by year, Intangibles was $570,000 in FY2024 (-37.4%), $910,000 in FY2023 (-22.8%) and $1.18 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 18.08 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 46.65 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 56.65 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 24.48 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 11.40 Bn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 38.15 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 19.54 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 13.42 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 45.96 Bn
10 Odyssey Therapeutics 929.15 Mn -64.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 86,000.00
Mar 31, 2026 160,000.00
Dec 31, 2025 262,000.00
Dec 31, 2024 570,000.00
Sep 30, 2024 696,000.00
Dec 31, 2023 910,000.00
Dec 31, 2022 1.18 Mn
API Access

Odyssey Therapeutics Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=intangibles&ticker=ODTX&period=max&api_key=YOUR_API_KEY